Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
Biocidal product factsheet - Last updated: 04/10/2024
Biocidal product factsheet
Trade name:
-
Brodifacoum (bloky 25 ppm) – profesionální použití
Brodifacoum 25 ppm Blocks - Professional
Brodifacoum 25 ppm Blocks - Professional Use
BRODIFACOUM 25 PPM BLOCKS – PROFESSIONAL USE
Brodifacoum 25ppm Blocks - Professional and Non-Professional Use
BRODIFACOUM 25ppm rágcsálóirtó blokk (szakképzett és lakossági felhasználás)
Brodifacoum zavitki 25 ppm - Za profesionalno uporabo
Brodikill Bloque 25
Final 25 Blox
FINAL 25 rágcsálóirtó blokk
Final25 Blox
Jaguar 25 Blox
JAGUAR 25 rágcsálóirtó blokk
Latigo Plus Bloque
Roe-Block Forte
Solo 25 Blox
SOLO 25 rágcsálóirtó blokk
Product-type:
PT14
Substance name:
IUPAC name:
3-[3-(4'-bromobiphenyl- 4-yl)-1,2,3,4-tetrahydro -1-napthyl]-4-hydroxycoumarin
EC number:
259-980-5
CAS number:
56073-10-0
BAS number:
11
The Active Substance is a candidate for substitution
Authorisation type:
National authorisation
Legal act:
Assessment reports:
Authorisation number | SPC | Decisions | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Brodifacoum 25 ppm Blocks - Professional Use Final 25 Blox Jaguar 25 Blox Solo 25 Blox |
PT14
|
Netherlands |
Bell Laboratories Netherlands B.V. | NL-0017725-0000 | NL-0017725-0000 | 05/04/2019 | 09/10/2029 |
|
20241002 NL0017725-0000 Renewal.docx (nl) 20221212 - Bell Laboratories- amendment.pdf (nl) 20221230_NL-0017725-0000_Decision.pdf (nl) |
Authorised |
Jaguar 25 Blox Solo 25 Blox |
PT14
|
Austria |
Bell Laboratories Netherlands B.V. | AT-0021635-0000 | AT-0021635-0000 | 05/04/2019 | 01/07/2025 |
Brodifacoum_25_ppm_Blocks_-_Professional Use_Bescheid_BMNT-UW.1.2.5_0601-V_5_2019.pdf (de) Brodifacoum_25_ppm_Blocks_-_Professional_Use_Anlage_1.pdf (de) |
Authorised | |
Final 25 Blox Jaguar 25 Blox Solo 25 Blox |
PT14
|
Belgium |
Bell Laboratories Netherlands B.V. | BE-0021324-0000 | BE2019-0072 | 05/04/2019 | 01/07/2025 |
|
BE2019-0072_ACT.pdf (fr) |
Authorised |
- |
PT14
|
Croatia |
Bell Laboratories Netherlands B.V. | HR-0030366-0000 | KLASA:UP/I-543-04/22-12/35 | 05/04/2019 | 01/07/2025 |
Rjesenje o produzetku isteka Brodifacoum 25ppm Blocks - Professional and Non-Professional Use.pdf (hr) rjesenje_Brodifacoum 25ppm Blocks - Professional and Non-Professional Use_HR.pdf (hr) |
Authorised | |
Brodifacoum (bloky 25 ppm) – profesionální použití Final 25 Blox Jaguar 25 Blox Solo 25 Blox |
PT14
|
Czech Republic |
Bell Laboratories Netherlands B.V. | CZ-0030302-0000 | CZ-0030302-0000 | 12/06/2023 | 01/07/2024 |
SPC not available |
Expired | |
BRODIFACOUM 25 PPM BLOCKS – PROFESSIONAL USE FINAL25 BLOX JAGUAR 25 BLOX SOLO 25 BLOX |
PT14
|
France |
Bell Laboratories Netherlands B.V. | FR-0021232-0000 | FR-2020-0004 | 31/01/2020 | 01/07/2024 |
SPC not available |
Expired | |
- |
PT14
|
Germany |
Bell Laboratories Netherlands B.V. | DE-0021834-0000 | DE-0021834-14 | 20/03/2020 | 01/07/2025 | Authorised | ||
Final25 Blox Jaguar 25 Blox Solo 25 Blox |
PT14
|
Greece |
Bell Laboratories Netherlands B.V. | GR-0021488-0000 | ΤΠ14-0156 | 16/08/2019 | 01/07/2025 |
SOLO-BLOCK_25_EXT._JANUARY_2023s.pdf (el) SOLO BLOX 25_VAR FEBRUARY 2023.pdf (el) SOLO 25 BLOX EXT. JUNE 2024.pdf (el) SOLO BLOX 25 MRP.pdf (el) |
Authorised | |
BRODIFACOUM 25ppm rágcsálóirtó blokk (szakképzett és lakossági felhasználás) FINAL 25 rágcsálóirtó blokk JAGUAR 25 rágcsálóirtó blokk SOLO 25 rágcsálóirtó blokk |
PT14
|
Hungary |
Bell Laboratories Netherlands B.V. | HU-0030387-0000 | HU-2023-MA-14-00440-0000 | 05/04/2019 | 31/12/2026 |
31543-1-2024 BRODIFACOUM 25ppm r�gcs�l�irt� blokk AAT decision.pdf (hu) |
Authorised | |
Jaguar 25 Blox Solo 25 Blox |
PT14
|
Ireland |
Bell Laboratories Netherlands B.V. | IE-0022150-0000 | IE/BPA 70784 | 05/04/2019 | 01/07/2025 | Authorised | ||
Final25 Blox Jaguar 25 Blox Solo 25 Blox |
PT14
|
Italy |
Bell Laboratories Netherlands B.V. | IT-0023907-0000 | IT/2020/00653/MRS | 05/04/2019 | 31/12/2026 |
Blocchi di Brodifacoum da 25 mg.pdf (it) |
Authorised | |
Brodifacoum 25 ppm Blocks - Professional Brodifacoum 25ppm Blocks - Professional and Non-Professional Use Final 25 Blox Jaguar 25 Blox Solo 25 Blox |
PT14
|
Luxembourg |
Bell Laboratories Netherlands B.V. | LU-0030298-0000 | 36/23/L-000 | 03/03/2023 | 01/07/2025 |
PROLONG__Brodifacoum25ppmBlocksProfessionalandNonProfessionalUse.pdf (fr) AMM__Brodifacoum25ppmBlocksProfessionalandNonProfessionalUse.pdf (fr) |
Authorised | |
- |
PT14
|
Poland |
Bell Laboratories Netherlands B.V. | PL-0030154-0000 | PL/2023/0601/MR | 05/04/2019 | 01/07/2024 |
SPC not available |
Expired | |
Brodifacoum zavitki 25 ppm - Za profesionalno uporabo Final 25 Blox Jaguar 25 Blox Solo 25 Blox |
PT14
|
Slovenia |
Bell Laboratories Netherlands B.V. | SI-0030245-0000 | SI-0030245-0000 | 09/01/2023 | 01/07/2025 | Authorised | ||
Brodikill Bloque 25 Final 25 Blox Jaguar 25 Blox Latigo Plus Bloque Roe-Block Forte Solo 25 Blox |
PT14
|
Spain |
Bell Laboratories Netherlands B.V. | ES-0021773-0000 | ES/MR(NA)-2020-14-00680 | 05/04/2019 | 01/07/2025 |
R4BP3-ES-0021773-0000-Authorisation.pdf (es) R4BP3-ES-0021773-0000-Authorisation.pdf (es) R4BP-ES-0021773-0000-Authorisation.pdf (es) |
Authorised | |
Final25 Blox Jaguar 25 Blox Solo 25 Blox |
PT14
|
Switzerland |
Bell Laboratories Netherlands B.V. | CH-0022167-0000 | CH-2020-0004 | 28/01/2020 | 01/07/2025 | Authorised | ||
Brodifacoum 25 ppm Blocks - Professional Use Jaguar 25 Blox Solo 25 Blox |
PT14
|
United Kingdom |
Bell Laboratories UK Ltd | UK-0021302-0000 | UK-2020-1239 | 16/03/2020 | 31/12/2020 |
SPC not available |
Expired |
Authorisation number: NL-0017725-0000| Market area: Netherlands
8 assessment records available
Evaluating authority:
Netherlands
Conclusion date:
02/10/2024
Start date:
05/04/2019
End date:
09/10/2029
SPC not available
Evaluating authority:
Netherlands
Conclusion date:
30/04/2024
Start date:
05/04/2019
End date:
01/07/2025
SPC not available
Evaluating authority:
Netherlands
Conclusion date:
22/12/2022
Start date:
05/04/2019
End date:
01/07/2024
SPC not available
Evaluating authority:
Netherlands
Conclusion date:
13/12/2022
Start date:
05/04/2019
End date:
01/07/2024
SPC not available
Evaluating authority:
Netherlands
Conclusion date:
14/02/2020
Start date:
05/04/2019
End date:
05/04/2024
SPC not available
Evaluating authority:
Netherlands
Conclusion date:
05/11/2019
Start date:
05/04/2019
End date:
05/04/2024
SPC not available
Evaluating authority:
Netherlands
Conclusion date:
02/04/2019
Start date:
05/04/2019
End date:
05/04/2024
SPC not available
Authorisation number: AT-0021635-0000| Market area: Austria
3 assessment records available
Evaluating authority:
Austria
Conclusion date:
26/01/2023
Start date:
05/04/2019
End date:
01/07/2024
SPC not available
Evaluating authority:
Austria
Conclusion date:
30/10/2019
Start date:
23/10/2019
End date:
05/04/2024
SPC not available
Authorisation number: BE-0021324-0000| Market area: Belgium
6 assessment records available
Evaluating authority:
Belgium
Conclusion date:
10/04/2024
Start date:
05/04/2019
End date:
01/07/2024
SPC not available
Evaluating authority:
Belgium
Conclusion date:
20/01/2023
Start date:
05/04/2019
End date:
05/04/2024
SPC not available
Evaluating authority:
Belgium
Conclusion date:
22/01/2020
Start date:
05/04/2019
End date:
05/04/2024
SPC not available
Evaluating authority:
Belgium
Conclusion date:
20/01/2020
Start date:
05/04/2019
End date:
05/04/2024
SPC not available
Evaluating authority:
Belgium
Conclusion date:
15/01/2020
Start date:
05/04/2019
End date:
05/04/2024
SPC not available
Authorisation number: HR-0030366-0000| Market area: Croatia
2 assessment records available
Evaluating authority:
Croatia
Conclusion date:
07/04/2023
Start date:
31/01/2023
End date:
01/07/2024
SPC not available
Authorisation number: CZ-0030302-0000| Market area: Czech Republic
1 assessment record available
Evaluating authority:
Czech Republic
Conclusion date:
12/06/2023
Start date:
12/06/2023
End date:
01/07/2024
SPC not available
Authorisation number: FR-0021232-0000| Market area: France
4 assessment records available
Evaluating authority:
France
Conclusion date:
27/03/2023
Start date:
31/01/2020
End date:
01/07/2024
SPC not available
Evaluating authority:
France
Conclusion date:
14/11/2022
Start date:
31/01/2020
End date:
01/07/2024
SPC not available
Evaluating authority:
France
Conclusion date:
03/02/2020
Start date:
31/01/2020
End date:
05/04/2024
SPC not available
Evaluating authority:
France
Conclusion date:
31/01/2020
Start date:
31/01/2020
End date:
04/04/2024
SPC not available
Authorisation number: DE-0021834-0000| Market area: Germany
3 assessment records available
Evaluating authority:
Germany
Conclusion date:
21/03/2024
Start date:
05/04/2019
End date:
01/07/2024
SPC not available
Evaluating authority:
Germany
Conclusion date:
12/03/2020
Start date:
12/03/2020
End date:
05/04/2024
SPC not available
Authorisation number: GR-0021488-0000| Market area: Greece
4 assessment records available
Evaluating authority:
Greece
Conclusion date:
03/02/2023
Start date:
16/08/2019
End date:
01/07/2024
SPC not available
Evaluating authority:
Greece
Conclusion date:
20/01/2023
Start date:
16/08/2019
End date:
01/07/2024
SPC not available
Evaluating authority:
Greece
Conclusion date:
12/09/2019
Start date:
16/08/2019
End date:
05/04/2024
SPC not available
Authorisation number: HU-0030387-0000| Market area: Hungary
3 assessment records available
Evaluating authority:
Hungary
Conclusion date:
03/02/2023
Start date:
03/02/2023
End date:
01/07/2024
SPC not available
Evaluating authority:
Hungary
Conclusion date:
03/02/2023
Start date:
03/02/2023
End date:
01/07/2024
SPC not available
Authorisation number: IE-0022150-0000| Market area: Ireland
3 assessment records available
Evaluating authority:
Ireland
Conclusion date:
15/04/2024
Start date:
05/04/2019
End date:
01/07/2024
SPC not available
Evaluating authority:
Ireland
Conclusion date:
27/01/2020
Start date:
27/01/2020
End date:
05/04/2024
SPC not available
Authorisation number: IT-0023907-0000| Market area: Italy
4 assessment records available
Evaluating authority:
Italy
Conclusion date:
15/05/2023
Start date:
05/04/2019
End date:
01/07/2024
SPC not available
Evaluating authority:
Italy
Conclusion date:
11/11/2022
Start date:
05/04/2019
End date:
01/07/2024
SPC not available
Evaluating authority:
Italy
Conclusion date:
10/09/2020
Start date:
12/06/2020
End date:
05/04/2024
SPC not available
Authorisation number: LU-0030298-0000| Market area: Luxembourg
2 assessment records available
Evaluating authority:
Luxembourg
Conclusion date:
17/03/2023
Start date:
03/03/2023
End date:
01/07/2024
SPC not available
Authorisation number: PL-0030154-0000| Market area: Poland
1 assessment record available
Evaluating authority:
Poland
Conclusion date:
22/12/2023
Start date:
05/04/2019
End date:
01/07/2024
SPC not available
Authorisation number: SI-0030245-0000| Market area: Slovenia
2 assessment records available
Evaluating authority:
Slovenia
Conclusion date:
11/01/2023
Start date:
09/01/2023
End date:
01/07/2024
SPC not available
Authorisation number: ES-0021773-0000| Market area: Spain
7 assessment records available
Evaluating authority:
Spain
Conclusion date:
01/03/2023
Start date:
22/01/2020
End date:
01/07/2024
SPC not available
Evaluating authority:
Spain
Conclusion date:
10/02/2023
Start date:
22/01/2020
End date:
01/07/2024
SPC not available
Evaluating authority:
Spain
Conclusion date:
02/09/2022
Start date:
22/01/2020
End date:
01/07/2024
SPC not available
Evaluating authority:
Spain
Conclusion date:
02/03/2020
Start date:
22/01/2020
End date:
05/04/2024
SPC not available
Evaluating authority:
Spain
Conclusion date:
02/03/2020
Start date:
22/01/2020
End date:
10/03/2020
SPC not available
Evaluating authority:
Spain
Conclusion date:
04/02/2020
Start date:
22/01/2020
End date:
10/03/2020
SPC not available
Authorisation number: CH-0022167-0000| Market area: Switzerland
5 assessment records available
Evaluating authority:
Switzerland
Conclusion date:
16/11/2023
Start date:
28/01/2020
End date:
01/07/2024
SPC not available
Evaluating authority:
Switzerland
Conclusion date:
09/02/2023
Start date:
28/01/2020
End date:
01/07/2024
SPC not available
Evaluating authority:
Switzerland
Conclusion date:
29/01/2020
Start date:
28/01/2020
End date:
05/04/2024
SPC not available
Evaluating authority:
Switzerland
Conclusion date:
28/01/2020
Start date:
05/04/2019
End date:
05/04/2024
SPC not available
Authorisation number: UK-0021302-0000| Market area: United Kingdom
2 assessment records available
Evaluating authority:
United Kingdom
Conclusion date:
26/08/2020
Start date:
16/03/2020
End date:
05/04/2024
SPC not available
Evaluating authority:
United Kingdom
Conclusion date:
17/03/2020
Start date:
16/03/2020
End date:
05/04/2024
SPC not available